Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity--a rebuttal.
Makris
M
M
Van Veen
J J
JJ
D001779:Blood Coagulation Factors / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D005167:Factor VII / Q000008:administration & dosage / Q000009:adverse effects*; D015942:Factor VIIa / Q000008:administration & dosage*; D006801:Humans; D015994:Incidence; D007262:Infusions, Intravenous; D011994:Recombinant Proteins / Q000008:administration & dosage* / Q000009:adverse effects*; D013223:Statistics as Topic / Q000379:methods*; D013927:Thrombosis / Q000139:chemically induced* / Q000453:epidemiology
D001779:Blood Coagulation Factors; D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa